Exosome Therapy Market, Global Outlook and Forecast 2022-2028

May 2022 | 63 pages | ID: EF9535A17BDDEN
Market Monitor Global

Abstracts

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.

This report contains market size and forecasts of Exosome Therapy in Global, including the following market information:

Global Exosome Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Exosome Therapy market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Direct Treatment Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Exosome Therapy include United Therapeutics Corporation, Codiak BioSciences, EngEx™, Esperite Group, ArunA Biomedical, Evox Therapeutics, NeurExo Sciences, Tavec Pharmaceuticals and AEGLE Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Exosome Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Exosome Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Exosome Therapy Market Segment Percentages, by Type, 2021 (%)

• Direct Treatment
• Drug Delivery Vehicle

Global Exosome Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Exosome Therapy Market Segment Percentages, by Application, 2021 (%)

• Hospital
• Clinic
• Research Institutions

Global Exosome Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Exosome Therapy Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Exosome Therapy revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Exosome Therapy revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• United Therapeutics Corporation
• Codiak BioSciences
• EngEx™
• Esperite Group
• ArunA Biomedical
• Evox Therapeutics
• NeurExo Sciences
• Tavec Pharmaceuticals
• AEGLE Therapeutics
• Avalon GloboCare
• AlligatorBioscience
• Capricor Therapeutics
• Stem Cell Medicine
• CellTex Therapeutics

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Exosome Therapy Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Exosome Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL EXOSOME THERAPY OVERALL MARKET SIZE

2.1 Global Exosome Therapy Market Size: 2021 VS 2028
2.2 Global Exosome Therapy Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Exosome Therapy Players in Global Market
3.2 Top Global Exosome Therapy Companies Ranked by Revenue
3.3 Global Exosome Therapy Revenue by Companies
3.4 Top 3 and Top 5 Exosome Therapy Companies in Global Market, by Revenue in 2021
3.5 Global Companies Exosome Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Exosome Therapy Players in Global Market
  3.6.1 List of Global Tier 1 Exosome Therapy Companies
  3.6.2 List of Global Tier 2 and Tier 3 Exosome Therapy Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Exosome Therapy Market Size Markets, 2021 & 2028
  4.1.2 Direct Treatment
  4.1.3 Drug Delivery Vehicle
4.2 By Type - Global Exosome Therapy Revenue & Forecasts
  4.2.1 By Type - Global Exosome Therapy Revenue, 2017-2022
  4.2.2 By Type - Global Exosome Therapy Revenue, 2023-2028
  4.2.3 By Type - Global Exosome Therapy Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Exosome Therapy Market Size, 2021 & 2028
  5.1.2 Hospital
  5.1.3 Clinic
  5.1.4 Research Institutions
5.2 By Application - Global Exosome Therapy Revenue & Forecasts
  5.2.1 By Application - Global Exosome Therapy Revenue, 2017-2022
  5.2.2 By Application - Global Exosome Therapy Revenue, 2023-2028
  5.2.3 By Application - Global Exosome Therapy Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Exosome Therapy Market Size, 2021 & 2028
6.2 By Region - Global Exosome Therapy Revenue & Forecasts
  6.2.1 By Region - Global Exosome Therapy Revenue, 2017-2022
  6.2.2 By Region - Global Exosome Therapy Revenue, 2023-2028
  6.2.3 By Region - Global Exosome Therapy Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Exosome Therapy Revenue, 2017-2028
  6.3.2 US Exosome Therapy Market Size, 2017-2028
  6.3.3 Canada Exosome Therapy Market Size, 2017-2028
  6.3.4 Mexico Exosome Therapy Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Exosome Therapy Revenue, 2017-2028
  6.4.2 Germany Exosome Therapy Market Size, 2017-2028
  6.4.3 France Exosome Therapy Market Size, 2017-2028
  6.4.4 U.K. Exosome Therapy Market Size, 2017-2028
  6.4.5 Italy Exosome Therapy Market Size, 2017-2028
  6.4.6 Russia Exosome Therapy Market Size, 2017-2028
  6.4.7 Nordic Countries Exosome Therapy Market Size, 2017-2028
  6.4.8 Benelux Exosome Therapy Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Exosome Therapy Revenue, 2017-2028
  6.5.2 China Exosome Therapy Market Size, 2017-2028
  6.5.3 Japan Exosome Therapy Market Size, 2017-2028
  6.5.4 South Korea Exosome Therapy Market Size, 2017-2028
  6.5.5 Southeast Asia Exosome Therapy Market Size, 2017-2028
  6.5.6 India Exosome Therapy Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Exosome Therapy Revenue, 2017-2028
  6.6.2 Brazil Exosome Therapy Market Size, 2017-2028
  6.6.3 Argentina Exosome Therapy Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Exosome Therapy Revenue, 2017-2028
  6.7.2 Turkey Exosome Therapy Market Size, 2017-2028
  6.7.3 Israel Exosome Therapy Market Size, 2017-2028
  6.7.4 Saudi Arabia Exosome Therapy Market Size, 2017-2028
  6.7.5 UAE Exosome Therapy Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 United Therapeutics Corporation
  7.1.1 United Therapeutics Corporation Corporate Summary
  7.1.2 United Therapeutics Corporation Business Overview
  7.1.3 United Therapeutics Corporation Exosome Therapy Major Product Offerings
  7.1.4 United Therapeutics Corporation Exosome Therapy Revenue in Global Market (2017-2022)
  7.1.5 United Therapeutics Corporation Key News
7.2 Codiak BioSciences
  7.2.1 Codiak BioSciences Corporate Summary
  7.2.2 Codiak BioSciences Business Overview
  7.2.3 Codiak BioSciences Exosome Therapy Major Product Offerings
  7.2.4 Codiak BioSciences Exosome Therapy Revenue in Global Market (2017-2022)
  7.2.5 Codiak BioSciences Key News
7.3 EngEx™
  7.3.1 EngEx™ Corporate Summary
  7.3.2 EngEx™ Business Overview
  7.3.3 EngEx™ Exosome Therapy Major Product Offerings
  7.3.4 EngEx™ Exosome Therapy Revenue in Global Market (2017-2022)
  7.3.5 EngEx™ Key News
7.4 Esperite Group
  7.4.1 Esperite Group Corporate Summary
  7.4.2 Esperite Group Business Overview
  7.4.3 Esperite Group Exosome Therapy Major Product Offerings
  7.4.4 Esperite Group Exosome Therapy Revenue in Global Market (2017-2022)
  7.4.5 Esperite Group Key News
7.5 ArunA Biomedical
  7.5.1 ArunA Biomedical Corporate Summary
  7.5.2 ArunA Biomedical Business Overview
  7.5.3 ArunA Biomedical Exosome Therapy Major Product Offerings
  7.5.4 ArunA Biomedical Exosome Therapy Revenue in Global Market (2017-2022)
  7.5.5 ArunA Biomedical Key News
7.6 Evox Therapeutics
  7.6.1 Evox Therapeutics Corporate Summary
  7.6.2 Evox Therapeutics Business Overview
  7.6.3 Evox Therapeutics Exosome Therapy Major Product Offerings
  7.6.4 Evox Therapeutics Exosome Therapy Revenue in Global Market (2017-2022)
  7.6.5 Evox Therapeutics Key News
7.7 NeurExo Sciences
  7.7.1 NeurExo Sciences Corporate Summary
  7.7.2 NeurExo Sciences Business Overview
  7.7.3 NeurExo Sciences Exosome Therapy Major Product Offerings
  7.7.4 NeurExo Sciences Exosome Therapy Revenue in Global Market (2017-2022)
  7.7.5 NeurExo Sciences Key News
7.8 Tavec Pharmaceuticals
  7.8.1 Tavec Pharmaceuticals Corporate Summary
  7.8.2 Tavec Pharmaceuticals Business Overview
  7.8.3 Tavec Pharmaceuticals Exosome Therapy Major Product Offerings
  7.8.4 Tavec Pharmaceuticals Exosome Therapy Revenue in Global Market (2017-2022)
  7.8.5 Tavec Pharmaceuticals Key News
7.9 AEGLE Therapeutics
  7.9.1 AEGLE Therapeutics Corporate Summary
  7.9.2 AEGLE Therapeutics Business Overview
  7.9.3 AEGLE Therapeutics Exosome Therapy Major Product Offerings
  7.9.4 AEGLE Therapeutics Exosome Therapy Revenue in Global Market (2017-2022)
  7.9.5 AEGLE Therapeutics Key News
7.10 Avalon GloboCare
  7.10.1 Avalon GloboCare Corporate Summary
  7.10.2 Avalon GloboCare Business Overview
  7.10.3 Avalon GloboCare Exosome Therapy Major Product Offerings
  7.10.4 Avalon GloboCare Exosome Therapy Revenue in Global Market (2017-2022)
  7.10.5 Avalon GloboCare Key News
7.11 AlligatorBioscience
  7.11.1 AlligatorBioscience Corporate Summary
  7.11.2 AlligatorBioscience Business Overview
  7.11.3 AlligatorBioscience Exosome Therapy Major Product Offerings
  7.11.4 AlligatorBioscience Exosome Therapy Revenue in Global Market (2017-2022)
  7.11.5 AlligatorBioscience Key News
7.12 Capricor Therapeutics
  7.12.1 Capricor Therapeutics Corporate Summary
  7.12.2 Capricor Therapeutics Business Overview
  7.12.3 Capricor Therapeutics Exosome Therapy Major Product Offerings
  7.12.4 Capricor Therapeutics Exosome Therapy Revenue in Global Market (2017-2022)
  7.12.5 Capricor Therapeutics Key News
7.13 Stem Cell Medicine
  7.13.1 Stem Cell Medicine Corporate Summary
  7.13.2 Stem Cell Medicine Business Overview
  7.13.3 Stem Cell Medicine Exosome Therapy Major Product Offerings
  7.13.4 Stem Cell Medicine Exosome Therapy Revenue in Global Market (2017-2022)
  7.13.5 Stem Cell Medicine Key News
7.14 CellTex Therapeutics
  7.14.1 CellTex Therapeutics Corporate Summary
  7.14.2 CellTex Therapeutics Business Overview
  7.14.3 CellTex Therapeutics Exosome Therapy Major Product Offerings
  7.14.4 CellTex Therapeutics Exosome Therapy Revenue in Global Market (2017-2022)
  7.14.5 CellTex Therapeutics Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Exosome Therapy Market Opportunities & Trends in Global Market
Table 2. Exosome Therapy Market Drivers in Global Market
Table 3. Exosome Therapy Market Restraints in Global Market
Table 4. Key Players of Exosome Therapy in Global Market
Table 5. Top Exosome Therapy Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Exosome Therapy Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Exosome Therapy Revenue Share by Companies, 2017-2022
Table 8. Global Companies Exosome Therapy Product Type
Table 9. List of Global Tier 1 Exosome Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Exosome Therapy Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Exosome Therapy Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Exosome Therapy Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Exosome Therapy Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Exosome Therapy Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Exosome Therapy Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Exosome Therapy Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Exosome Therapy Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Exosome Therapy Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Exosome Therapy Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Exosome Therapy Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Exosome Therapy Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Exosome Therapy Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Exosome Therapy Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Exosome Therapy Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Exosome Therapy Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Exosome Therapy Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Exosome Therapy Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Exosome Therapy Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Exosome Therapy Revenue, (US$, Mn), 2023-2028
Table 30. United Therapeutics Corporation Corporate Summary
Table 31. United Therapeutics Corporation Exosome Therapy Product Offerings
Table 32. United Therapeutics Corporation Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 33. Codiak BioSciences Corporate Summary
Table 34. Codiak BioSciences Exosome Therapy Product Offerings
Table 35. Codiak BioSciences Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 36. EngEx™ Corporate Summary
Table 37. EngEx™ Exosome Therapy Product Offerings
Table 38. EngEx™ Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 39. Esperite Group Corporate Summary
Table 40. Esperite Group Exosome Therapy Product Offerings
Table 41. Esperite Group Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 42. ArunA Biomedical Corporate Summary
Table 43. ArunA Biomedical Exosome Therapy Product Offerings
Table 44. ArunA Biomedical Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 45. Evox Therapeutics Corporate Summary
Table 46. Evox Therapeutics Exosome Therapy Product Offerings
Table 47. Evox Therapeutics Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 48. NeurExo Sciences Corporate Summary
Table 49. NeurExo Sciences Exosome Therapy Product Offerings
Table 50. NeurExo Sciences Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 51. Tavec Pharmaceuticals Corporate Summary
Table 52. Tavec Pharmaceuticals Exosome Therapy Product Offerings
Table 53. Tavec Pharmaceuticals Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 54. AEGLE Therapeutics Corporate Summary
Table 55. AEGLE Therapeutics Exosome Therapy Product Offerings
Table 56. AEGLE Therapeutics Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 57. Avalon GloboCare Corporate Summary
Table 58. Avalon GloboCare Exosome Therapy Product Offerings
Table 59. Avalon GloboCare Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 60. AlligatorBioscience Corporate Summary
Table 61. AlligatorBioscience Exosome Therapy Product Offerings
Table 62. AlligatorBioscience Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 63. Capricor Therapeutics Corporate Summary
Table 64. Capricor Therapeutics Exosome Therapy Product Offerings
Table 65. Capricor Therapeutics Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 66. Stem Cell Medicine Corporate Summary
Table 67. Stem Cell Medicine Exosome Therapy Product Offerings
Table 68. Stem Cell Medicine Exosome Therapy Revenue (US$, Mn), (2017-2022)
Table 69. CellTex Therapeutics Corporate Summary
Table 70. CellTex Therapeutics Exosome Therapy Product Offerings
Table 71. CellTex Therapeutics Exosome Therapy Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Exosome Therapy Segment by Type in 2021
Figure 2. Exosome Therapy Segment by Application in 2021
Figure 3. Global Exosome Therapy Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Exosome Therapy Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Exosome Therapy Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Exosome Therapy Revenue in 2021
Figure 8. By Type - Global Exosome Therapy Revenue Market Share, 2017-2028
Figure 9. By Application - Global Exosome Therapy Revenue Market Share, 2017-2028
Figure 10. By Region - Global Exosome Therapy Revenue Market Share, 2017-2028
Figure 11. By Country - North America Exosome Therapy Revenue Market Share, 2017-2028
Figure 12. US Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Exosome Therapy Revenue Market Share, 2017-2028
Figure 16. Germany Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 17. France Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Exosome Therapy Revenue Market Share, 2017-2028
Figure 24. China Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 28. India Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Exosome Therapy Revenue Market Share, 2017-2028
Figure 30. Brazil Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Exosome Therapy Revenue Market Share, 2017-2028
Figure 33. Turkey Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Exosome Therapy Revenue, (US$, Mn), 2017-2028
Figure 37. United Therapeutics Corporation Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Codiak BioSciences Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. EngEx™ Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Esperite Group Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. ArunA Biomedical Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Evox Therapeutics Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. NeurExo Sciences Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Tavec Pharmaceuticals Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. AEGLE Therapeutics Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Avalon GloboCare Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. AlligatorBioscience Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Capricor Therapeutics Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Stem Cell Medicine Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CellTex Therapeutics Exosome Therapy Revenue Year Over Year Growth (US$, Mn) & (2017-2022)